Researchers develop low-cost technology to detect cancer

NewsGuard 100/100 Score

While many college football fans are focused on this week's marquee matchup between the Georgia Bulldogs and the Clemson Tigers, researchers from the two institutions are working together off the playing field to develop low-cost technology that can detect cancer.

Jian He, assistant professor of physics and astronomy at Clemson, and Leidong Mao, associate professor in the College of Engineering at the University of Georgia, discovered a system to measure magnetic properties of materials by combining their knowledge of ferrofluids, or liquid magnets, and microfluidics, fluids that are geometrically constrained to a small, typically sub-millimeter, scale.

"Conventional equipment for measuring magnetic properties of materials is large and expensive," Mao said. "By combining these two technologies, we are able to measure magnetic properties of materials using a low-cost, small device that works quickly and leaves a small footprint."

The researchers use their technology to isolate cancer cells with magnetic particles from a sample.

"Being able to measure magnetic properties in a low-cost and fast fashion is of great importance in the area of biomedical research," said He. "We aim to use our technique not only to measure magnetic properties, but also as a diagnostic tool to distinguish between normal cells and cancer cells in the long run."

This research collaboration will continue to build on current results of their technology and apply to other types of applications including materials research and cancer diagnostics.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer